BiochemProbe — Life Science Research Reagents

AZD-5069 free base · Synonyms: AZD 5069 · AZD5069

AZD-5069 is a potent CXCR2 chemokine receptor antagonist.

For research use only. Not for human or veterinary use.

Target CXCR
Research area Endocrinology Cancer
Purity >98% Stock Inquire

AZD-5069 structure

CAS No.: 878385-84-3

Download structure (.mol)

Pack sizes & pricing

Size Price SKU Stock
50 mg USD 315.00 BP-02095-50mg In stock Get quote
100 mg USD 504.00 BP-02095-100mg In stock Get quote
250 mg USD 1,008.00 BP-02095-250mg In stock Get quote
500 mg USD 1,610.00 BP-02095-500mg In stock Get quote
1 g USD 2,580.00 BP-02095-1g In stock Get quote
2 g USD 4,130.00 BP-02095-2g In stock Get quote
3 g Inquire BP-02095-3g In stock Inquire

Need another size or custom synthesis? Request a quote.

Description

AZD-5069 is a potent CXCR2 chemokine receptor antagonist, used for caner treatment.

Biological activity

In Vitro AZD-5069 (Compound 2) acts as CXCR2 antagonist by inhibition of [125I]-IL-8 binding to human CXCR2 receptors and as inhibitor of GROα-induced Ca2+ flux in human neutrophils loaded with fluo-3 dye.

Identifiers

SMILES
C[C@@H](OC1=CC(NS(=O)(=O)N2CCC2)=NC(SCC2=CC=CC(F)=C2F)=N1)[C@@H](O)CO
InChIKey
QZECRCLSIGFCIO-RISCZKNCSA-N

Specifications

MW (average)
476.5180
Formula
C18H22F2N4O5S2
CAS No.
878385-84-3
Physical state
Solid
Color
White to light yellow
Shipping
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage
Powder -20℃ 2 years; In solvent -20℃ 1 month;

Solubility

Soluble in DMSO

References

[1]. Norman P, et al. Evidence on the identity of the CXCR2 antagonist AZD-5069. Expert Opin Ther Pat. 2013 Jan;23(1):113-7.

Same target

Search CXCR

Same research area

Search Endocrinology